about
Mechanisms and management of stroke in the elderly.The "top 50": a perspective on the BMJ drawn from the Science Citation IndexRisk Factors Associated with the Requirement for Pharmaceutical Intervention in the Hospital Setting: A Systematic Review of the LiteratureAdverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsContribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly.Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reportsAdverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981-2007: less rapid increase, different drugsDrug surveillance data in a Canadian hospital.Using routinely collected prescribing data to determine drug persistence for the purpose of pharmacovigilance.Adverse reactions in patients with rheumatic diseases. Retrospective analysis of causes of admission and out-patient attendance in a specialist centre.Medication and the elderly. Issues of prescription and use.Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.Drug prescribing for the elderly.A pharmacovigilance study in the department of medicine of a university teaching hospital.Questionable prescribing for elderly patients in Quebec.Suspected adverse drug reactions in elderly patients reported to the Committee on Safety of MedicinesComparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.A comparison of isoxicam pharmacokinetics in young and elderly subjects.Theophylline pharmacokinetics in advanced age.Changes in drug metabolism with increasing age: 1. warfarin binding and plasma proteins.Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patientsThe effect of age on plasma levels of propranolol and practolol in man.Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam.Factors affecting drug binding in plasma of elderly patients.Age related differences in the disposition of acetanilide.A pharmacovigilance study in medicine department of tertiary care hospital in chhattisgarh (jagdalpur), India.The development and evaluation of an integrated electronic prescribing and drug management system for primary careMedical home care services for the housebound elderly.Pharmacokinetics of aztreonam in elderly male volunteersGenetic control of nortriptyline kinetics in man: a study of relatives of propositi with high plasma concentrations.Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.Clinical pharmacology: drugs and the elderlyDrug-related problems in hospitalized patients on polypharmacy: the influence of age and gender.The clinical aspects of drugs and disease of the skinDrugs in the elderly.Pattern of Angiotensin-converting enzyme inhibitors induced adverse drug reactions in South Indian teaching hospitalSleep without drugs.A prospective study of adverse drug reactions in hospitalized childrenA survey of adverse drug reactions in family practice.Principles of pharmacotherapy: I. Pharmacodynamics.
P2860
Q24537145-123CC008-EB29-45F2-83A4-476AB601DD37Q24678708-E6E2EB17-E831-41EA-8146-6F334D26D156Q28075471-023FE8EB-51B1-4345-9FFD-57631BFF4224Q28169189-184C21E4-685C-44B6-AF02-9765AAEBB778Q28360739-D8E3814A-1994-4335-A0DE-B0EA2E5355FBQ28379131-9EFC7A07-6516-425A-ABF3-FDDE50371196Q28476135-C62F9646-D374-40FE-A5D6-A11B43270EB0Q33186180-37D86EA0-5533-4BAC-8FD7-E0B57DE1D901Q33558310-BF0A5C03-7B6F-4BC9-9F68-FF5011E5F42CQ33568747-C0409744-25FC-4ED2-8FB5-D3D593CCE6D8Q33630080-A0F7CBB0-2AD8-4A84-B574-C104E5212D0AQ33741136-131EE9D1-B02B-4918-A110-63C0774C1FE3Q34110511-46A557BD-5B39-4861-8F64-7AE7DA2C557FQ34136377-95EB702D-BD62-454D-A0A7-F24F76A3E5ABQ34276987-F80B3BF5-6845-4CE5-B851-3E30B334A97DQ34418047-37979392-B06C-4F46-8566-CC77A25EFCC7Q34447414-7B6D86F0-8E05-4F3A-AE1C-FD917182F964Q34447420-25BF17ED-FA2C-40F8-8AE3-C8FFEB643935Q34449761-AD51A98B-5947-4702-9D86-9DE2064EABC8Q34451452-680FF0FE-3484-4C19-9946-9664E6D87E8DQ34451653-B24C3831-B5E9-450A-94A8-40D7E9E408AAQ34451732-E0078E14-AA53-45C4-8B43-893DF5296BB7Q34512330-086BA374-AD09-4252-8322-6681E54F7275Q34515177-ADC14D48-BBDD-4381-A846-908940164C08Q34517680-D32EA291-C664-4357-BBFA-7DCE62F66454Q34561751-5963B4B8-649D-41E5-8C78-6EE955406ACFQ34565242-877C427A-DD2B-4E83-8C72-9B6B684BEFB2Q34578969-F8794CA6-CAB2-4488-BBE7-33D73D9FD107Q34622283-F050C6EC-C3E9-4237-9561-0F80B3E7956EQ34634249-E0861C4B-15BD-4DA4-BCF2-D1BB66299D05Q34635172-05D46131-229A-4BDA-8B0E-EA87B22406FDQ34776373-A0AE8E00-8666-474E-8685-F62220A9ECE8Q35166646-42F1923C-1757-4CC3-84F5-0C17A4FB564BQ35241943-FF9FD39F-4561-4958-9C83-43016A8FD758Q35651099-B1366B05-BFCB-4001-882A-8CFF2692848EQ35906518-C0DEB1DD-3B74-4A86-8553-962A688F444FQ35985698-CA2F708A-A1D4-4290-93F2-42E721CA829DQ36053473-280AEADD-B617-49A4-903D-84CF2E67F178Q36299003-B28ED3CA-5788-4BC5-B6ED-76FB1CDDA04FQ36313287-CEBF9447-7E78-4592-92A7-A835644D3D9B
P2860
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh-hant
name
Predisposing factors in adverse reactions to drugs.
@en
Predisposing factors in adverse reactions to drugs.
@nl
type
label
Predisposing factors in adverse reactions to drugs.
@en
Predisposing factors in adverse reactions to drugs.
@nl
prefLabel
Predisposing factors in adverse reactions to drugs.
@en
Predisposing factors in adverse reactions to drugs.
@nl
P2860
P356
P1433
P1476
Predisposing factors in adverse reactions to drugs.
@en
P2093
P2860
P304
P356
10.1136/BMJ.1.5643.536
P407
P577
1969-03-01T00:00:00Z